METTL3, as the writer of m6A, plays a pivotal tumour-suppressor role in PTC carcinogenesis through c-Rel and RelA inactivation of the nuclear factor κB (NF-κB) pathway to regulate tumour growth9. Here, REL is linked to neoplasm.